Life Sciences & Biotechnology, COVID-19 Technology
Title: | Andrographolide, Neoandrographolides and Graphisides |
Area: | Life Sciences & Biotechnology, COVID-19 Technology |
Focus Area: | Development of Repurposed Drugs for COVID-19 |
Developing Agency: | Central Drug Research Institute (CSIR-CDRI), Lucknow |
Technology Readiness Index: | Commercialized |
| Website Link : | https://www.cdri.res.in/Home.aspx |
Brief Description
Description : | The Lab has isolated important andrographolide, neo-andrographolides and graphisides from the plant for testing their efficacy against SARS-CoV-2/ COVID-19. In silico target-based screening studies suggests that some of these can inhibit critical proteins like the CL-proteinase of the pathogen. |
Related Technologies